Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Osiris Therapeutics, Inc.
Columbia, Maryland, United Statesosiris.com ↗
- Ownership
- Public · OSIR
- Employees
- ~161
- Development stage
- Other
01
Overview
Osiris Therapeutics developed the world's first approved stem cell drug (Prochymal/remestemcel-L) for pediatric Graft-versus-Host Disease. The company achieved commercial success with products in orthopedics, sports medicine, and wound care, including BIO4, Cartiform, and Grafix.
- Therapeutic areas
- GastroenterologyCardiovascularRheumatologyImmunologyEndocrinologyDermatology
- Modalities
- Stem CellsCellular TherapiesTissue-based Products
- Industry
- Biotech
02
Partnerships
Department of Veteran AffairsDepartment of DefenseHowmedica Osteonics Corp.Mesoblast LimitedStryker Corporation
Beyond the preview
Go deeper on Osiris Therapeutics, Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Osiris Therapeutics, Inc..